Skip to main content
Updating results

Approval

  • Updated

Answer: The Food and Drug Administration said it granted approval to a drug from Biogen based on clinical research results that seemed “reasonably likely” to benefit Alzheimer’s patients.

  • Updated

Answer: They will likely request some documentation first that the patient needs the drug. Many plans will require doctors to submit records and other paperwork justifying the treatment before they agree to cover it.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News